Join Daxor Corporation at the Medaxiom Cardiovascular Transforum Conference Spring23 to Discover the Revolutionary BVA-100 Blood Volume Diagnostic and Elevate Awareness

marketnews04 mins

Expert Users to Present “Blood Volume Analysis – Breaking the Heart Failure Cycle” at MedAxiom CV Transforum Spring’23 Conference Oak Ridge, TN, April 17, 2023 (GLOBE NEWSWIRE) Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will be exhibiting at the MedAxiom CV Transforum Spring’23 Conference being held at…

Read More

Five Intelligent Reasons to Consider Gold ETFs as Shrewd Investments Amid Current Market Conditions

ilikefinance05 mins

Gold Prices Soar and Retreat: A Closer Look On the morning of Feb. 3, 2025, gold bullion reached an unprecedented peak, surpassing $2,830 per ounce. This significant milestone was a result of various economic factors, primarily geopolitical tensions and inflation concerns. Factors Contributing to the Gold Price Surge One of the primary drivers of the…

Read More

SEC Chief Issues Warning on Crypto Investments as Bitcoin ETF Deadline Approaches

newscaster04 mins

The Risks of Investing in Crypto: Understanding Gary Gensler’s Cautionary Statements Spot Bitcoin Exchange-Traded Product Approval Amid the anticipation surrounding the potential approval of a spot Bitcoin exchange-traded product by the Securities and Exchange Commission (SEC), the Chairman’s, Gary Gensler, recent cautionary statements have cast a spotlight on the inherent risks within the crypto landscape….

Read More

Moleculin’s Global Exclusivity Reinforced: New Patent Allowances for Anticancer Drug Annamycin

marketnews06 mins

Moleculin Biotech’s European Patent Extension: Moleculin Biotech, a Nasdaq-listed, late-stage pharmaceutical company, recently announced that it has received a Notice of Intent to Grant for the European patent application titled, “Method of Reconstituting Liposomal Annamycin.” This patent extension comes after the successful grant of similar patents in the United States and affirms the company’s intellectual…

Read More

Identiv Reveals Q4 and Fiscal Year 2024 Financial Results: A Closer Look at the Company’s Performance

marketnews05 mins

Perform-Accelerate-Transform Strategy: Identiv’s Q4 & Fiscal Year 2024 Financial Results In a recent press release, Identiv, Inc., a pioneer in RFID-enabled Internet of Things (IoT) solutions, shared their financial results for the fourth quarter and the entire fiscal year 2024, which ended on December 31, 2024. The company’s stock is traded on the NASDAQ under…

Read More

Alarum Technologies Ltd. Securities Fraud Lawsuit: An Opportunity for Alar Investors to Take Legal Action

marketinsights05 mins

Class Action Lawsuit Filed Against Alarum Technologies Ltd. by Rosen Law Firm New York, NY – Rosen Law Firm, a prominent investor rights law firm, has announced the filing of a class action lawsuit against Alarum Technologies Ltd. (Alarum) (NASDAQ: ALAR) on behalf of all persons who purchased securities of Alarum between March 14, 2024,…

Read More